课题基金 / 基金详情

MOLECULAR INTEGRITY OF FVIII IN COMMERCIAL FVIII CONCENTRATES

MOLECULAR INTEGRITY OF FVIII IN COMMERCIAL FVIII CONCENTRATES
商业 FVIII 浓缩物中 FVIII 的分子完整性
批准号:
3804911
负责人:
M A LAMB
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

M A LAMB的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Since FVIII is highly susceptible to proteolysis, purification processes used in the manufacture of FVIII may result in fragmentation, activation and/or degradation of the FVIII molecule. The molecular integrity of a variety of currently available FVIII concentrates as well as several preparations which are in development is being determined. An immunoprecipitation procedure has been developed for isolating FVIII from commercial concentrates. Polyclonal rabbit IgG against recombinant FVIII has been purified by Protein A chromatography and absorbed with immobilized PPF to remove antibodies to other proteins. The resulting IgG preparation has been coupled to CNBr activated agarose. This solid phase immunoabsorbent is being used to immunoprecipitate FVIII from commercial concentrates. Immunoprecipitates are being electrophoresed on SDS PAGE. FVIII protein is being visualized using the Western blot technique with enzyme linked antibodies. Western blots of FVIII from the various concentrates are being compared with regard to the size and relative distribution of FVIII polypeptides.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COAGULATION FACTOR IX STANDARDIZATION STUDY
STANDARDS FOR ASSAY OF VON WILLEBRAND FACTOR--A COLLABORATIVE STUDY
VON WILLEBRAND FACTOR STANDARDIZATION STUDY
海外基金